Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-119737
Filing Date
2024-11-15
Accepted
2024-11-15 16:31:10
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2428189-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2428189-1_3seq1.xml 3 12365
  Complete submission text file 0001104659-24-119737.txt   14869
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Reporting) CIK: 0001472322 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 241468334

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Mack Daniel (Reporting) CIK: 0001775831 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 241468332

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Harkey Wilmot B. (Reporting) CIK: 0001775952 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 241468333